Psoriasis Clinical Trials

Find Psoriasis Clinical Trials Near You

An Open-label Extension Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of ORKA-001 in Participants With Moderate-to-Severe Plaque Psoriasis

Status: Recruiting

Location: See all (10) locations...

Intervention Type: Drug

Study Type: Interventional

Study Phase: Phase 2

SUMMARY

An open-label extension (OLE) study to evaluate the long-term safety and efficacy of ORKA-001 in adult participants with moderate-to-severe plaque psoriasis, who previously participated in an Oruka Therapeutics sponsored study.

Eligibility

Participation Requirements

Sex: All

Minimum Age: 18

Healthy Volunteers: f

View:

• Signed informed consent by participants from previous trial choosing to transition into the OLE.

• Participants who have successfully completed the preceding trial.

• For women of childbearing potential, must have a negative urine pregnancy test at Baseline visit.

• For women of childbearing potential and fertile male participants with a partner of childbearing potential must be willing to continue to use highly effective contraception

Locations

United States

California